
Opinion|Videos|July 3, 2024
Investigational Therapies Paving New PNH Treatment Pathways
Dr Haumschild continues leading a discussion surrounding potential treatment advancements in the PNH landscape.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Looking towards the future, what advancements do you anticipate in the treatment landscape for PNH and other complement-driven rare diseases, particularly in relation to investigational therapeutics targeting the alternative pathway?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
New PBM Laws Seek to Protect Independent Pharmacies but Could Raise Costs, Limit Patient Access
3
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
4
Measles Outbreaks Cause Financial, Public Health Burden in US
5
















































